Sten Madsbad
Researcher Next ID · RN-006693
Researcher · Medicine
Copenhagen, Denmark
- Works count
- 795
- Citation count
- 38,257
- H-index
- 101
- i10-index
- 434
Research interests
Publications
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30069-7
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa042274
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)07952-7
Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
Diabetes · 2001 · https://doi.org/10.2337/diabetes.50.3.609
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
The Journal of Clinical Endocrinology & Metabolism · 2001 · https://doi.org/10.1210/jcem.86.8.7750
Current projects
No projects listed.